about
Chronic inhibition of GABA synthesis in the bed nucleus of the stria terminalis elicits anxiety-like behaviorThe Deakin/Graeff hypothesis: focus on serotonergic inhibition of panic.Etiology, triggers and neurochemical circuits associated with unexpected, expected, and laboratory-induced panic attacksTopographical distribution of corticotropin-releasing factor type 2 receptor-like immunoreactivity in the rat dorsal raphe nucleus: co-localization with tryptophan hydroxylaseSocial learning and amygdala disruptions in Nf1 mice are rescued by blocking p21-activated kinaseFrom QTL to candidate gene: a genetic approach to alcoholism researchThe role of the medial prefrontal cortex in regulating social familiarity-induced anxiolysis.Orexin 1 receptors are a novel target to modulate panic responses and the panic brain network.Repeated stimulation of CRF receptors in the BNST of rats selectively induces social but not panic-like anxiety.A key role for orexin in panic anxiety.Evaluation of JNJ-54717793 a Novel Brain Penetrant Selective Orexin 1 Receptor Antagonist in Two Rat Models of Panic Attack Provocation.Changes in central sodium and not osmolarity or lactate induce panic-like responses in a model of panic disorderDisruption of GABAergic tone in the dorsomedial hypothalamus attenuates responses in a subset of serotonergic neurons in the dorsal raphe nucleus following lactate-induced panic.Neural pathways underlying lactate-induced panic.Group II metabotropic glutamate receptor type 2 allosteric potentiators prevent sodium lactate-induced panic-like response in panic-vulnerable rats.A selective orexin-1 receptor antagonist attenuates stress-induced hyperarousal without hypnotic effectsSuppression of inflammatory and neuropathic pain by uncoupling CRMP-2 from the presynaptic Ca²⁺ channel complexAnatomic and functional topography of the dorsal raphe nucleus.A functional subset of serotonergic neurons in the rat ventrolateral periaqueductal gray implicated in the inhibition of sympathoexcitation and panic.Activation of the orexin 1 receptor is a critical component of CO2-mediated anxiety and hypertension but not bradycardia.Pharmacological depletion of serotonin in the basolateral amygdala complex reduces anxiety and disrupts fear conditioning.Dorsomedial/Perifornical hypothalamic stimulation increases intraocular pressure, intracranial pressure, and the translaminar pressure gradientModulation of anxiety circuits by serotonergic systems.Hypothalamic orexin's role in exacerbated cutaneous vasodilation responses to an anxiogenic stimulus in a surgical menopause modelElectroacupuncture Promotes Central Nervous System-Dependent Release of Mesenchymal Stem Cells.Sustained relief of ongoing experimental neuropathic pain by a CRMP2 peptide aptamer with low abuse potential.Neuropeptide Y in the amygdala induces long-term resilience to stress-induced reductions in social responses but not hypothalamic-adrenal-pituitary axis activity or hyperthermia.Angiotensin II's role in sodium lactate-induced panic-like responses in rats with repeated urocortin 1 injections into the basolateral amygdala: amygdalar angiotensin receptors and panic.Evaluation of Low versus High Volume per Minute Displacement CO₂ Methods of Euthanasia in the Induction and Duration of Panic-Associated Behavior and Physiology.Multiple anxiogenic drugs recruit a parvalbumin-containing subpopulation of GABAergic interneurons in the basolateral amygdala.OREXIN 1 AND 2 RECEPTOR INVOLVEMENT IN CO2 -INDUCED PANIC-ASSOCIATED BEHAVIOR AND AUTONOMIC RESPONSES.Acute carbon dioxide exposure in healthy adults: evaluation of a novel means of investigating the stress response.Are tuberomammillary histaminergic neurons involved in CO2-mediated arousal?Serotonergic systems associated with arousal and vigilance behaviors following administration of anxiogenic drugs.Local inhibition of organic cation transporters increases extracellular serotonin in the medial hypothalamus.Angiotensin-II is a putative neurotransmitter in lactate-induced panic-like responses in rats with disruption of GABAergic inhibition in the dorsomedial hypothalamus.Panic-prone state induced in rats with GABA dysfunction in the dorsomedial hypothalamus is mediated by NMDA receptors.A selective, non-peptide CRF receptor 1 antagonist prevents sodium lactate-induced acute panic-like responses.PSD95 and nNOS interaction as a novel molecular target to modulate conditioned fear: relevance to PTSDCorrigendum to "Hypothalamic orexin's role in exacerbated cutaneous vasodilation responses to an anxiogenic stimulus in a surgical menopause model" [Psychoneuroendocrinology 65 (2016) 127-137]
P50
Q24631248-D88CC651-E0C6-4C8E-B50C-C9CF1703A2F3Q27022602-87C0B847-22DB-4A71-BE00-80CA1EC9375DQ27026213-0557BB49-62BB-4EEA-9999-56F414553659Q28569531-806D1912-B6DE-47F9-AA45-82FCB5FDCE45Q28592608-E75815D2-EEA6-495A-B562-16D697B26EB8Q30409923-E229099E-3B83-4476-B114-23C23D39EFA8Q30417829-F621C2ED-60AF-4253-AF64-7DF1AC42ABACQ30446233-7B7B7EAD-2143-43A1-A651-45286B6DCDCDQ30476186-A4BD2E91-2CB4-41EA-BB6E-635AB314D55EQ30480814-F06A2C1A-3D14-4B8B-80CE-5B8DA00414FBQ33780634-1B761514-31E3-484B-A129-BC88CA34F209Q33793925-0472A457-8B4C-4A72-9EAB-0A6471861AF9Q34726690-08FE2D3E-7E86-447C-BD09-A0E91DD51D01Q34726741-EE187BC9-4B48-4FAE-987A-47DE6E8D63E9Q34992163-4B504489-3053-43EE-8581-E416B865DE10Q35156407-8F8E052C-AACA-4B21-A9D7-1A6A1085162CQ35561043-5B5275ED-A947-4D55-BEBB-7E74594565F6Q35829259-9BFE2D28-2290-4DD9-A24C-40EA05000683Q35829263-A8841DCE-65EE-43FD-941E-83BA7E11AD39Q36035937-815A43C0-3416-45C2-A07E-76A7D9EE13AAQ36243777-B8226272-8210-4491-B667-59DE46FF38BFQ36366790-21186D80-8D54-437F-9E96-B5A4AD3B442EQ36372784-E7766279-B382-4F0D-8F08-5EE00F746236Q36578173-19D24F69-6E6D-4E63-8604-974FBB999FF7Q39158320-B122ED44-74E6-4936-9409-AB2A007254CFQ39168504-79440719-DBBB-4936-86CE-06C77081F2BCQ39274637-84329120-9688-4BC7-8840-32AD3067B577Q41099024-46C04551-4DBA-482C-BEAE-C07A0D357553Q41210056-5C4A82EF-0359-48BD-B5D1-4D1130A24D45Q41959174-0EB1A10E-BB99-4C05-80A4-304B96898969Q43065862-EB56FCFD-BBCA-486C-9DD6-A9E1F542DB31Q44818542-E54964D9-8EB7-472B-BC1D-AB64316308B5Q46427447-BB71169D-AEDC-4F51-9C7F-32698FB2AEF4Q46510078-87C8C35F-E3AF-44E1-9BBC-68353CE89336Q46788001-2A266943-BF67-44C6-B5A4-2BD3D554FBE7Q48427606-FD261765-7B9C-4C45-86F8-75E95FF57E26Q48484032-13D4D9DA-8A9A-4513-93A9-6707BDA414C0Q48960253-1BF35C90-EC0F-474B-ADB4-4C67B18CEF09Q58783067-F6553171-DE09-4A5F-A857-AA488E98DC86Q88269869-CBF33516-1B02-4DD5-82C4-8D14EC5C0F6B
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Philip L Johnson
@ast
Philip L Johnson
@en
Philip L Johnson
@es
Philip L Johnson
@nl
type
label
Philip L Johnson
@ast
Philip L Johnson
@en
Philip L Johnson
@es
Philip L Johnson
@nl
prefLabel
Philip L Johnson
@ast
Philip L Johnson
@en
Philip L Johnson
@es
Philip L Johnson
@nl
P106
P31
P496
0000-0002-5398-8214